Abstract
The incidence of mucormycosis showed a sharp rise during the COVID-19 pandemic in vulnerable populations like people with diabetes. Here, we report a case of mucormycosis of the frontal and ethmoid sinuses in a man in his mid-50s with a background of diabetes mellitus and COVID-19 infection requiring steroids and oxygen support. The infection had remained persistent despite initial debridement by functional endoscopic sinus surgery of the anterior frontal sinus wall and re-exploration, followed by debridement using the brow incision. The patient had received an entire course of systemic antifungal therapy during the postoperative period. A bifrontal craniotomy, excision of the supraorbital ridge and complete removal of bilateral frontal sinuses managed the persistent fungal infection. The defect was reconstructed with a custom-made three-dimensional-printed MRI-compatible titanium cranioplasty mesh. The patient had no signs of infection on the 9-month follow-up.
Reference15 articles.
1. Necrosis of maxilla, nasal, and frontal bone secondary to extensive rhino-cerebral mucormycosis;Verma;Natl J Maxillofac Surg,2013
2. The spectrum of invasive fungal sinusitis in COVID-19 patients;Baghel;J Fungi (Basel),2022
3. Mucormycoses
4. Sugar AM . In. Mandell GL, Bennett JE, Dolin R(eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. New York, USA: Churchill Livingstone, 2000.
5. Skiada A , Pavleas I , Drogari-Apiranthitou M . Epidemiology and diagnosis of Mucormycosis: an update. J Fungi (Basel) 2020;6:265. doi:10.3390/jof6040265